Anticoagulation in high-risk patients: when is this approach not worth the risk?
- 30 September 2000
- journal article
- editorial
- Published by Elsevier in The American Journal of Medicine
- Vol. 109 (4) , 335-337
- https://doi.org/10.1016/s0002-9343(00)00542-8
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Withholding treatment in patients with acute pulmonary embolism who have a high risk of bleeding and negative serial noninvasive leg testsThe American Journal of Medicine, 2000
- Use of a Clinical Model for Safe Management of Patients with Suspected Pulmonary EmbolismAnnals of Internal Medicine, 1998
- Hemorrhagic Complications of Anticoagulant TreatmentChest, 1998
- Pulmonary EmbolismNew England Journal of Medicine, 1998
- Bleeding and Thromboembolism During Anticoagulant Therapy:A Population-Based Study in Rochester, MinnesotaMayo Clinic Proceedings, 1995
- Untreated Patients With Pulmonary EmbolismChest, 1995
- Anticoagulant-related bleeding: Clinical epidemiology, prediction, and preventionThe American Journal of Medicine, 1993
- Risk Factors for Complications of Chronic Anticoagulation: A Multicenter StudyAnnals of Internal Medicine, 1993
- A bleeding risk index for estimating the probability of major bleeding in hospitalized patients starting anticoagulant therapyThe American Journal of Medicine, 1990
- Value of the Ventilation/Perfusion Scan in Acute Pulmonary EmbolismJAMA, 1990